ENVB - CIK 0000890821
Enveric Biosciences, Inc. has filed 1,004 documents with the SEC between 1998 and 2026. The most frequent type is major company event (259 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| EFFECT | - | 2025-12-08 | - |
| Company correspondence | CORRESP | 2025-12-08 | - |
| S-3/A | - | 2025-12-05 | - |
| SCHEDULE 13G | - | 2025-12-05 | - |
| SCHEDULE 13G | - | 2025-12-05 | - |
| Quarterly report | 10-Q | 2025-11-14 | 2025-09-30 |
| Major company event | 8-K | 2025-11-14 | 2025-11-12 |
| Major company event | 8-K | 2025-11-14 | 2025-11-14 |
| SCHEDULE 13G | - | 2025-11-13 | - |
| Proxy statement | DEF 14A | 2025-10-27 | 2025-10-27 |
| Major company event | 8-K | 2025-10-23 | 2025-10-22 |
| PRE 14A | - | 2025-10-10 | 2025-10-10 |
| SCHEDULE 13G | - | 2025-10-03 | - |
| D | - | 2025-10-03 | - |
| SEC correspondence | UPLOAD | 2025-09-30 | - |
| Securities registration | S-3 | 2025-09-29 | - |
| SCHEDULE 13G | - | 2025-09-24 | - |
| Major company event | 8-K | 2025-09-18 | 2025-09-17 |
| Major company event | 8-K | 2025-09-02 | 2025-09-02 |
| Major company event | 8-K | 2025-08-29 | 2025-08-29 |
| Major company event | 8-K | 2025-08-29 | 2025-08-26 |
| Quarterly report | 10-Q | 2025-08-14 | 2025-06-30 |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| Major company event | 8-K | 2025-06-03 | 2025-05-29 |
| Quarterly report | 10-Q | 2025-05-14 | 2025-03-31 |
| Major company event | 8-K | 2025-05-14 | 2025-05-14 |
| Insider trade | 4 | 2025-05-12 | 2025-05-08 |
| Insider trade | 4 | 2025-05-12 | 2025-05-08 |
| Insider trade | 4 | 2025-05-12 | 2025-05-08 |
| EFFECT | - | 2025-04-17 | - |
| Company correspondence | CORRESP | 2025-04-16 | - |
| Annual report to shareholders | ARS | 2025-04-16 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-15 | - |
| Proxy statement | DEF 14A | 2025-04-15 | 2025-04-15 |
| Major company event | 8-K | 2025-04-14 | 2025-04-14 |
| S-3/A | - | 2025-04-10 | - |
| PRE 14A | - | 2025-04-04 | 2024-12-31 |
| SCHEDULE 13G/A | - | 2025-04-02 | - |
| Major company event | 8-K | 2025-03-31 | 2025-03-31 |
| Annual report | 10-K | 2025-03-28 | 2024-12-31 |
| Employee stock plan | S-8 | 2025-03-24 | - |
| Major company event | 8-K | 2025-03-06 | 2025-03-04 |
| Major company event | 8-K | 2025-02-26 | 2025-02-26 |
| SCHEDULE 13G | - | 2025-02-05 | - |
| SCHEDULE 13G/A | - | 2025-02-04 | - |
| SCHEDULE 13G | - | 2025-02-04 | - |
| Major company event | 8-K | 2025-02-03 | 2025-01-30 |
| 424B4 | - | 2025-02-03 | - |
| EFFECT | - | 2025-01-30 | - |
| S-1/A | - | 2025-01-30 | - |